Skip to content

ABTEST© Card Clinical Perfomance Study

Clinical Perfomance Study of the ABTEST© Card in Vitro Medical Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05140395
Enrollment
100
Registered
2021-12-01
Start date
2021-06-06
Completion date
2021-11-04
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfusion Reaction

Keywords

Reagent Kits, Diagnostic

Brief summary

The study confirms the performance equivalence of the in vitro Diagnostic reagent ABTEST card used with the new reformulated WS solution

Detailed description

The study consists to perform on 100 patients a first pre transfusional control with the reference in vitro reagent ABTEST card (CE Marked reagent) followed by a another pre transfusional control with the in vitro reagent ABTEST card in study (new reformulated WS solution used) .

Interventions

DIAGNOSTIC_TESTABTEST card

Pre transfusional control with the referent ABTEST card and the in study ABDTEST Card

Sponsors

Diagast
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

in situ used for near patient In vitro Medical device

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

66 patients in hematology / oncology departments , including 20 patients with a hemoglobin significantly below the norm (\<8g / dl hemoglobin in the blood), and about to receive a transfusion. 20 patients hospitalized in gastroenterology with a transfusion need 4 internal medicine patients with cold agglutinins, in a transfusion context or not. 10 neonatal patients, background transfusion or Guthrie test.

Design outcomes

Primary

MeasureTime frameDescription
Agreement between two reagents5 minutesperformance of pre transfusional controls with the referent reagent and the reagent in study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026